Skip to content

Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.

Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05853185
Acronym
GCP
Enrollment
64
Registered
2023-05-10
Start date
2021-10-12
Completion date
2022-08-30
Last updated
2023-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpitis - Irreversible

Brief summary

Although many pulpotomy agents are commercially available, there is a dearth of clinical research comparing the efficacy of these agents in treating individuals with irreversible pulpitis. Bioceramic and MTA both have similar clinical uses, but Bioceramic is distinguished from MTA by its superior chemical, physical, and biological properties. This study aims to address this knowledge deficit by assessing the performance of biocompatible materials in pulpotomy procedures for the treatment of symptomatic permanent teeth in adults with deep caries. For permanent teeth with a completed root and a diagnosis of irreversible pulpitis without apical periodontitis, this research will compare the success rates of MTA and EBRRM pulpotomy procedures in order to provide evidence-based clinical practice guidelines for the treatment of this disease.

Detailed description

The goal of this observational study is to test and compare the success of full pulpotomy with Mineral Trioxide Aggregate (MTA) pre-mixed bioceramic in mature teeth with irreversible pulpitis. Participants in this study were patients with irreversible pulpitis without apical periodontal pathosis recruited from the waiting list at the School of Dentistry at Liaquat University of Medical and Health Sciences in Jamshoro. After obtaining informed consent, demographic information, clinical examination results, and binary variables were recorded pre- and intra-operatively. The study's primary aim was to assess postoperative pain, and secondary aims included assessing the presence of swelling, sinusitis, or fistula and detecting tooth mobility. Participants received either MTA or Endo Sequence Bioceramic Root Repair randomly allocated using a lottery system. Follow-up assessments were done initially, after 6 days, and after 6 months, and periapical radiography was done at 6 days and 6 months to detect radiolucency.

Interventions

DRUGPro Root MTA®

Patients in this group will receive the pulpotomy with Pro Root MTA®.

DRUGEBRRM®

Patients in this group will receive the pulpotomy with Endo Sequence Bioceramic Root Repair (EBRRM)®.

Sponsors

Liaquat University of Medical & Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
10 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patients with diagnosis of irreversible pulpitis without apical periodontitis 2. Either gender 3. Lower Age 10 Years - Upper Age 40 Years

Exclusion criteria

* Teeth displaying indications of resorption. * Teeth that have not fully developed, characterized by open apices. * Canals that are calcified or obstructed. * Perforations that were caused by the dentist. * Fractures in the root * Teeth that cannot be restored * • Teeth that are unable to withstand frigid temperatures, have a sinus infection, or have swelling around them. * There has been no pulp exposure despite the removal of carious lesion. * Ten minutes after a pulpotomy, hemorrhage could not be stopped. * Necrotic or partly necrotic pulp is indicated by insufficient bleeding after exposure.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Success at 6 Months6 MonthsNumber of participants with clinical success based on following criteria * No complaints of pain or discomfort outside of the initial two days following therapy. * The tooth shows no signs of pain upon palpation or percussion. * A probing pocket depth of less than 4 mm and 1 mm are indicative of normal movement. * No inflammation or sinus tract can be seen in the soft tissues around the teeth.

Secondary

MeasureTime frameDescription
Radiographic Success6 MonthsNumber of participants with clinical success based on absence of Root resorption, furcal pathosis, or fresh periapical pathosis on the radiograph

Countries

Pakistan

Participant flow

Recruitment details

Department of Operative Dentistry & Endodontics, Liaquat University of Medical and Health Sciences, Jamshoro

Pre-assignment details

All participants fulfilling the inclusion criteria consented for the study.

Participants by arm

ArmCount
Pro Root MTA®
Patients in this group will receive the pulpotomy with Pro Root MTA®. Pro Root MTA®: Patients in this group will receive the pulpotomy with Pro Root MTA®.
32
EBRRM®
Patients in this group will receive the pulpotomy with Endosequence Bioceramic Root Repair Material (EBRRM)®. EBRRM®: Patients in this group will receive the pulpotomy with Endo Sequence Bioceramic Root Repair (EBRRM)®.
32
Total64

Baseline characteristics

CharacteristicEBRRM®TotalPro Root MTA®
Age, Continuous31.25 Years
STANDARD_DEVIATION 11.322
30.72 Years
STANDARD_DEVIATION 10.868
30.19 Years
STANDARD_DEVIATION 10.548
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Pakistan
32 Participants64 Participants32 Participants
Sex: Female, Male
Female
9 Participants25 Participants16 Participants
Sex: Female, Male
Male
23 Participants39 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 320 / 32
other
Total, other adverse events
0 / 320 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Clinical Success at 6 Months

Number of participants with clinical success based on following criteria * No complaints of pain or discomfort outside of the initial two days following therapy. * The tooth shows no signs of pain upon palpation or percussion. * A probing pocket depth of less than 4 mm and 1 mm are indicative of normal movement. * No inflammation or sinus tract can be seen in the soft tissues around the teeth.

Time frame: 6 Months

Population: Clinical Outcome Success at 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pro Root MTA®Clinical Success at 6 Months27 Participants
EBRRM®Clinical Success at 6 Months30 Participants
Secondary

Radiographic Success

Number of participants with clinical success based on absence of Root resorption, furcal pathosis, or fresh periapical pathosis on the radiograph

Time frame: 6 Months

Population: Patients with no radiographic findings at 6 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Pro Root MTA®Radiographic Success30 Participants
EBRRM®Radiographic Success32 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026